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Borderline Personality Disorder (BPD) is a severe, challenging to treat mental disorder.
Schema therapy (ST) as an individual therapy has been proven to be an effective
psychological treatment for BPD. A group format of ST (GST) has been developed
and evaluated in a randomized controlled trial in the United States and piloted in
The Netherlands. These results suggest that GST speeds up and amplifies treatment
effects of ST and might reduce delivery costs. However, feasibility in the German
health care system and with BPD patients with high BPD severity and comorbidity,
and frequent hospitalization, has not been tested to date. We investigated GST in 10
severely impaired, highly comorbid female patients with BPD, that needed frequent
hospital admission. Patients received an outpatient ST-treatment program with weekly
group and individual sessions for 1 year. Outcome measures including BPD severity,
general psychopathology, psychosocial functioning, quality of life, happiness, schemas,
and modes, and days of hospitalization were assessed at the start of treatment and 6,
12, and 36 months later with semi-structured interviews and self-report measures. We
observed significant decreases in severity of BPD symptoms, general symptom severity,
dysfunctional BPD-specific modes and schemas, and days of hospitalization. Functional
modes, quality of live and happiness improved. The results of this feasibility study are
promising and encourage further implementation of ST outpatient treatment programs
even for patients with severe BPD and high hospitalization risk. However, small sample
size and the missing of a control group do not allow the generalizability of these findings.
Keywords: borderline personality disorder, schema therapy, group psychotherapy, feasibility studies, outpatients,
ambulatory care, personality disorder, cognitive behavior therapy
INTRODUCTION
Borderline Personality Disorder (BPD) is a severe mental disorder posing a significant burden
on the individual, their families and partners, health care systems and society as a whole. BPD is
characterized by a pervasive pattern of instability in interpersonal relationships, self-image, affects,
and impulsive behavior (American Psychiatric Association, 2000, 2013). Prevalence is estimated to
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be 2.7% in non-clinical samples (Trull et al., 2010) and up to
10% in outpatient and 25% in inpatient populations (Widiger and
Weissman, 1991; Zimmerman et al., 2005). Without adequate
treatment BPD patients utilize a disproportionate amount
of inpatient and outpatient psychiatric treatment resources,
psychopharmacological treatments, crisis intervention, and other
medical services (e.g., surgical care for self-injury, hospitalization
after intoxications). The annual costs for untreated BPD in
Germany are estimated to be 8.69 billion € annually (Wunsch
et al., 2014). Most of the costs are incurred by hospitalizations
and day treatment (Wagner et al., 2013).
According to international guidelines psychotherapy
is the primary treatment of BPD (American Psychiatric
Association, 2001; NICE, 2009). There is no evidence that
pharmacological treatment may be effective as a comprehensive
treatment for BPD (Stoffers and Lieb, 2015). In the last decades
psychotherapeutic treatment of BPD has been significantly
improved by the development of BPD-specific methods such
as dialectical behavior therapy (DBT), schema therapy (ST),
transference-focused psychotherapy (TFP), and mentalization
based therapy (MBT) (Stoffers et al., 2012). These specific
structured psychotherapies have demonstrated efficacy in
reducing BPD-symptoms and general functioning (Stoffers et al.,
2012). Besides, ST and DBT have also shown impressive cost
reductions of direct and indirect health care costs of approx.
10,000 e per patient per year (van Asselt et al., 2008; Wagner
et al., 2014).
However, although these specifically designed treatment
programs are (cost)-effective and superior to less structured
standard care, implementation and dissemination lag behind.
Only a very limited number of patients with BPD receive
evidenced-based psychotherapy (Hermens et al., 2011).
Regarding the situation in the Germany there are a number of
inpatient treatment units specialized on BPD treatment. There
is an urgent need for the creation of specialized outpatient
treatment facilities.
Among the BPD-specific methods apt for outpatient
programs, ST shows particular promise as it was found to be
effective regarding all aspects of BPD and led to significant
improvements in quality of life (Jacob and Arntz, 2013;
Sempértegui et al., 2013). In the first study, a Dutch multicenter
randomized controlled trial (RCT) (N = 86), ST was compared
to TFP. Both treatments consisted of two individual sessions
per week over the course of 3 years. ST had significantly less
drop-outs, higher remission rates, a better reduction of BPD-
typical symptoms and general psychopathology (Giesen-Bloo
et al., 2006a). In addition, ST was more cost-effective (van Asselt
et al., 2008). A second Dutch study demonstrated successful
implementation of individual ST for patients with BPD in
general clinical practice showing comparably good effects with a
reduced frequency and duration of therapy (Nadort et al., 2009).
The high number of sessions in individual ST, although cost-
effective (van Asselt et al., 2008), causes high delivery costs, and
makes it problematic to treat all patients requesting it. Farrell and
Shaw developed a group format of ST (Group schema therapy,
GST) (Farrell and Shaw, 2012), aiming at a more efficient use
of resources. An RCT with 32 female BPD patients, comparing
treatment as usual (TAU) alone to 30 sessions of GST and
TAU, demonstrated the effectiveness of GST for the treatment of
BPD. The GST group showed very low drop-out, high remission
rates of BPD, reductions in BPD severity and general psychiatric
symptoms as well as improvements in psychosocial functioning
with large effect sizes after only 8 months of treatment (Farrell
et al., 2009). A second study on GST was a Dutch pilot study with
18 patients treated in a combined format of individual and group
ST. This study found large improvements in BPD-symptoms,
general psychopathology, schema (mode) measures, quality of
life, and happiness (Dickhaut and Arntz, 2013).
These results suggest that specific group factors may catalyze
effects of ST and GST may be particularly (cost−) effective.
To systemically investigate the clinical effectiveness and cost-
effectiveness of GST and to test different formats of delivery
of GST (GST only vs. a combination of group and individual
ST) a large international multicenter RCT on GST for BPD was
planned and is underway now (Wetzelaer et al., 2014).
Since feasibility of GST in the German health care system
and with BPD patients with high BPD severity and comorbidity
had not been tested yet we conducted a pilot study. This
study was performed as a pilot study within the frame of the
above mentioned international trial on GST (Netherlands Trial
Register, number NTR2392). The major aims were to investigate
whether a GST program can be implemented in a German
University outpatient treatment center under routine mental
health care conditions and whether GST is effective even in
patients with high BPD severity, high comorbidity, and a history
of frequent hospitalization.
METHODS
Patients
Ten female patients with a primary diagnosis of BPD with high
severity were asked to participate in the study. All patients had
multiple hospitalizations and outpatient treatments in the past
(including 90% of the patients receiving in- and/or outpatient
DBT). All but one also received multiple pharmacological
treatments. Despite this intensive treatment they were not in
remission and were on a waiting list for patients requiring
further treatment. Psychosocial functioning was also severely
impaired: None of the patients had paid work or was in an
education process, three of the patients had at least a day
structure with occupational therapy, two women lived in violent
partnerships, and none of the patients had a stable intimate
relationship without violence. Two patients lived in supervised
group housing. The mean age of the sample was 35 (SD 13
years). For the clinical diagnoses we used the Structural Clinical
Interview for DSM-IV (SCID I and II) (Fydrich et al., 1997;
Wittchen et al., 1997), see Tables 1, 2 for diagnoses. Patients had
a very high degree of comorbidity with a mean number of 5.1
(SD 1.8) comorbid axis-I-disorders, and 1.8 (SD 1.5) comorbid
personality disorders. (Note: Some patients had more than one
anxiety or addictive disorders.)
Inclusion criteria were age ≥18 years, a primary diagnosis
of BPD according to SCID-II, severity of BPD > 20 in the
BPD Severity Index, fourth edition (BPDSI-IV) (Giesen-Bloo
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TABLE 1 | Frequency of comorbid axis-I-disorders according to
SCID-I-Interview at baseline.
Axis-I-disorder N %
Affective disorder 10 100
Anxiety disorders, total 9 90
Posttraumatic stress disorder 7 70
Obsessive-compulsive disorder 4 40
Alcohol/drug dependency/misuse 7 70
Eating disorders 8 80
TABLE 2 | Frequency of comorbid axis-II-disorders according to
SCID-II-Interview at baseline.
Axis-II-disorder N %
Schizotypal PD 1 10
Paranoid personality disorder 4 40
Antisocial personality disorder 2 20
Avoidant personality disorder 6 60
Dependent personality disorder 3 30
Obsessive-compulsive personality disorder 2 20
et al., 2010; Kröger et al., 2013), an well validated semi-
structured clinical interview. Exclusion criteria were Major
Psychotic disorder (lifetime diagnosis), intellectual deficit (IQ
< 80), inadequate communication skills in the German
language and acute serious substance dependencies (DSM-IV)
requiring clinical detoxification. Exclusion criteria were reduced
to a minimum in order to reach a realistic and severely
disturbed population representative for the population attending
institutions providing maximum psychiatric care in Germany.
Treatment and Therapists
The treatment protocol consisted of a weekly 100 min group
session (with all 10 participants in one group) led by two
therapists following the GST protocol of Farrell and Shaw (Farrell
and Shaw, 2012) combined with weekly 60 min individual ST-
sessions following the protocol of Arntz and van Genderen
(2009) with the specific aim to support the group sessions. A
description of the integration of the two modalities is published
in Farrell and Shaw (2012). Therapists met once a week for
peer-supervision (60 min) and had weekly supervision with
Ida Shaw via Skype (60 min). In addition patients received
an optimization of their psychotropic medications (mainly
reducing polypharmacy), and in some cases occupational therapy
and/or consultations with social workers. This therapy program
was offered for one year. After this year treatment could
be continued if needed according to patients’ preferences
and clinical judgment. Five patients continued to receive ST
according to a reduced temporal schedule.
A total of eight therapists were involved in the treatments,
two of them as group and individual therapists, 6 as individual
therapists only. All therapists but one were in their first 5years
of psychotherapy training in cognitive behavioral therapy, six of
them were already specialized in the treatment of BPD, group
therapists had prior experiences with group treatment of BPD.
All therapists received ST for BPD training workshops (at least 4
days of training) and GST (at least 3 days of training, for group
therapist 6 days of training). The patients in this study were their
first patients treated with ST. Treatment integrity was monitored
by means of intensive supervision.
Before start of the group sessions 4–6 individual sessions were
provided to work out an individual case conceptualization using
the ST mode model, and to prepare the group sessions.
Central to all therapeutic interventions was the theoretical
model of ST for BPD. ST is based on the idea that aversive
childhood experiences, such as physical, sexual or emotional
abuse, emotional neglect, and lack of secure attachment, lead
to the development of dysfunctional schemas (basic mental
representations of the self, relationships to others and the
world) and specific emotional-cognitive-behavioral states, so-
called modes (Young et al., 2003). The disorder-specific concept
for BPD operates almost exclusively using the mode model. The
following modes are characteristic for BPD: (a) the vulnerable
child mode, (b) the angry/impulsive child mode, (c) the punitive
parent mode, (d) the detached protector mode. The healthy
modes (healthy adult mode and happy child mode) are usually
very weak in BPD.
Therapy goals are to support and comfort the vulnerable child
mode, to help the angry/impulsive child mode finding adequate
ways to deal with anger and getting needs met in non-impulsive
and functional ways, to fight the punitive parent mode, and to
reassure the detached protector mode, so that patients can reduce
their emotional avoidance and learn healthier strategies to deal
with emotions and relationships. A last important goal is to
strengthen the healthy modes.
Cognitive, experiential, and behavioral interventions are
employed, and the working alliance is characterized by “limited
reparenting,” i.e., within professional boundaries therapists
behave toward patients like good parents and fulfill some of
the needs the patients missed in childhood. This serves as
an antidote to traumatic experiences and leads to corrective
interpersonal experiences. In GST “limited reparenting” is
extended to the whole group and aims at providing a “healthy
family”-atmosphere to patients, giving them a sense of belonging
and safe connection with others. To create a safe atmosphere a
closed group design was chosen and a strong emphasis was placed
on setting ground rules for the treatment (e.g., confidentiality,
respectful behavior toward each other) and to maintain a specific
session structure, which is predictable for patients. Every group
session started with a safety imagery (“safety bubble”) to promote
safety and bonding, followed by a short opening round on
mode awareness. After a discussion of homework in the main
working phase a topic relevant for the patients and their stage of
therapy was addressed with ST-specific techniques, with a strong
emphasis on experiential techniques. After that a new homework
assignment was given. To reduce tension at the end of the session
an exercise activating the happy child mode was chosen. In the
first stage of treatment therapy focused on psychoeducation on
BPD, on the BPD relevant modes and how they will be worked
with in ST. In the following working phase of treatment the focus
was on mode change.
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In GST patients can validate, support, confront and advise one
another and often experience the reactions and responses of other
patients as more “real” than those of therapists. For these reasons,
GST might “catalyze” the change processes of ST and lead to
faster and deeper changes than individual ST alone (Farrell et al.,
2009).
Clinical Outcome Measures and
Assessments
The primary outcome was BPD severity assessed with the total
score of the Borderline Personality Disorder Severity Index version
IV (BPDSI-IV), a semi-structured interview rating all facets of
BPD pathology. It assesses frequency and severity of all 9 DSM-
IV BPD symptoms over the last 3 months. The total score
ranges between 0 and 90. The scores on subscales of the BPDSI-
IV provide information on the severity of each of the nine
dimensions of BPD. The BPDSI-IV shows excellent psychometric
features (Cronbach’s alpha= 0.85; interrater reliability 0.99, high
validity and sensitivity to change) (Giesen-Bloo et al., 2010;
Kröger et al., 2013). A cutoff of 15 points has been empirically
found to differ people with BPD from people without BPD;
our inclusion criterion of >20 has been used in several studies
(Giesen-Bloo et al., 2006a; Nadort et al., 2009; Dickhaut and
Arntz, 2013), as it reliable distinguished BPD from non-BPD
PDs, and indicates a severe BPD in need of treatment.
Secondary outcomes were assessed with the following
self-report instruments: The BPD checklist is a self-report
scale that assesses the subjective burden caused by BPD
manifestations. Suitability for use as a treatment outcome
measure has been established (Giesen-Bloo et al., 2006b). The
Brief Symptom Inventory (BSI) was used as an inventory of
general psychiatric symptoms. The BSI was developed from
its longer parent instrument, the SCL-90-R, and shows similar
good psychometric properties (Derogatis and Melisaratos,
1983). General psychosocial functioning and social/occupational
functioning was assessed by the Global Assessment of Functioning
(GAF) and the Social and Occupational Functioning Assessment
Scale (SOFAS) with a short semi-structured interview, based
on axis V of DSM-IV. The GAF is a valid scale of global
psychopathology and the SOFAS is a valid measure of social,
occupational and interpersonal functioning. Both instruments
have excellent interrater reliability (intraclass correlation
coefficients > 0.74) (Hilsenroth et al., 2000). Further, the total
score of the Work and Social Adjustment Scale (WSAS) was
used to investigate functional impairment. The WSAS assesses
functional impairment at the time of assessment in the domains
of work, household, social leisure, private leisure, and family
and relationships. It consists of 5 items with a score from 0
to 8. The maximum total score is 40, lower scores indicating
higher functioning. The WSAS has shown to be a reliable and
valid measure of impaired functioning (Cronbach’s alpha of
internal scale consistency ranged from 0.70 to 0.94, test-retest
correlation was 0.73) (Mundt et al., 2002). Quality of life was
assessed by means of two widely used and psychometrically
sound self-report instruments: the World Health Organization
Quality of Life questionnaire (WHOQOL-short, total score) (The
WHOQOL Group, 1998), and the thermometer scale of the
EuroQoL (range 0–100) (Brooks, 1996), which assesses primarily
subjective physical health state. Happiness was assessed with
the 1-item happiness question (Abdel-Khalek, 2006) validated in
more than 30 countries, with the following response possibilities:
(1) completely unhappy; (2) very unhappy; (3) fairly unhappy;
(4) neither happy nor unhappy; (5) fairly happy; (6) very happy;
(7) completely happy. For a single happiness item high test-retest
reliability (r = 0.86) and good validity have been reported
(Abdel-Khalek, 2006). ST-specific measures were the Schema
Mode Inventory (SMI) and the Young Schema Questionnaire—
short form (YSQ). The SMI consists of 143 items on 16 schema
modes and measures the extent to which dysfunctional as well
as functional modes are present at the time of assessment. It has
an acceptable internal consistency, adequate test-retest reliability
and moderate construct validity (Lobbestael et al., 2008, 2010).
We used the mean item score of dysfunctional modes and the
mean item score of functional modes as outcome. The YSQ is
used to measure the presence or absence of 16 core maladaptive
schemas at the time of assessment (Young, 1998). The YSQ has
an adequate internal consistency and good reliability (Baranoff
et al., 2006). The YSQ total score was used as outcome.
All outcome measures were employed before the start of
therapy (Baseline), and 3 (M1), 12 (M2), and 36 months (Follow-
up) later. All 10 patients completed the baseline assessment. One
patient missed M1, 2 patients each missed M2 and follow-up.
Furthermore yearly days of hospitalization were assessed in
the year before treatment, during treatment and in the first and
second year after the treatment interval. Inpatient days in the
University Hospital of Lubeck University, which was the main
hospital for participating patients, were taken from the internal
administration and management program. Moreover, inpatient
stays in other clinics were assessed via patient reports.
Statistical Analysis
The statistical analysis was based on the intention-to-treat
principle, using all available data from all participants that started
the treatment. For all variables except days of hospitalization
we used mixed regressions for longitudinal data as this method
can deal with missing data and yields more valid estimates of
effects than analyzing completers only or using last observation
carried forward imputations (Schafer and Graham, 2002). The
four assessment points over 36 months of all dependent variables
constituted the repeated measure (i.e., time). For the repeated
part, a compound symmetry (CS) model was chosen as having
the best fit for the covariance structure. For the fixed part,
time models were chosen based on visual inspection of the
observed means. For most variables, the change in year 1 was
approximately linear, followed by a much slower change in the
follow-up period of 2 years. In these cases, assessment (0, 1, 2, 3)
as a linear covariate represented the time effect. In a minority, the
change developed as a linear effect of time, thus represented by
year (0, 0.5, 1, 2). In a few cases the change was only obtained in
year one after which it stabilized, represented by a “segmented”
time effect (0, 0.5, 1, 1). In the happiness ratings we found one
outlier with a very deviant pattern of strongly reduced ratings.
Analysis of Happiness ratings was therefore done without this
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outlier. Moreover, for this variable AR1 covariance structure had
a superior fit above CS, and was therefore chosen.
Days of hospitalization were analyzed by means of mixed
Poisson regression with linear time effect (year).
Besides statistical significance, effect size estimates (ES)
according to Cohen (1988) were computed. ES for all assessments
except for days of hospitalization are based on the change
from Baseline to Follow-up (three years) estimate from mixed
regression analysis divided by baseline SD. For days of
hospitalization ES is based on change over 3 years and baseline
SD on transformed variables for Poisson regression.
RESULTS
Treatment, Drop-Out and Data Sets
Figure 1 shows a consort-style patient flow chart. Seven patients
completed the treatment. There was one treatment drop-out:
One patient decided to stop the treatment program after 4.5
months as she did not feel that ST was the right treatment for
her at that time point. This patient did not participate at M1
and M2, but participated in the follow-up-assessment. After 8
months two other patients stopped the treatment program: One
patient started professional training and could not organize to
attend group sessions anymore, the other patient started a new
job and quit the treatment program due to time constraints
and as she felt “healthy enough” and this in agreement with the
therapeutic team. Both continued with booster sessions once a
month and gave their commitment for further data assessment.
These two patients are not counted as “drop outs” as stopping
the treatment program was in consent with the therapeutic team.
After 1 year five of the patients received additional GST and
individual therapy sessions in reduced frequency.
Treatment Outcomes
Primary Outcome: BPD Severity
Results from the BPDSI-IV-interview are given in Table 3. A
significant reduction in the overall severity of BPD-symptoms
with a large ES was obtained. Seven of the nine DSM-IV criteria
decreased significantly.
Secondary Outcomes
Table 4 presents the results for the secondary outcome measures:
The subjective burden of BPD manifestations as experienced
by the patients (BPD-checklist; total score), general psychiatric
symptoms (BSI), and functional impairment (WSAS, total score)
decreased with high effect sizes. Psychosocial functioning (GAF)
and social, occupational and interpersonal functioning (SOFAS)
improved with high effect sizes. The improvement of GAF and
SOFAS seemed to occur during the treatment interval and to
stagnate in the follow-up period. As to quality of live and well-
being, theWHOQol total score and the happiness item increased,
while no changes in the EuroQol thermometer could be observed.
The ST specific measures improved with high effect sizes: The
mean item score for dysfunctional schema modes decreased,
while for the functional modes significant improvement could be
obtained. The YSQ total score also decreased.
Table 5 shows the days of hospitalizations per year. The
inpatient days reduced with a high effect size from an average
of 93 days in the year before the treatment program started to 4
days in the second follow-up year.
DISCUSSION
The present study supports feasibility of an outpatient ST
program with combined group and individual ST under routine
mental health care conditions in Germany. Even patients with
high BPD severity, a high degree of comorbidity, and frequent
hospitalizations can benefit from such a program. Therapists in
their first 5 years of cognitive behavioral training outside the
centers where ST and GST were developed can learn the method
and successfully offer it to patients.
Our findings demonstrate large improvements in BPD-typical
symptoms (both in objective and subjective perspective), general
psychiatric symptoms, and functional impairment. Psychosocial
functioning as well as social and occupational functioning was
increased and quality of life (according to the WHOQoL total
score) and general happiness improved. However, self-reported
evaluation of health state according to the EuroQol thermometer
did not improve. A remarkable finding was themassive reduction
of inpatient days in the treatment interval and throughout follow-
up suggesting that such a treatment program could lead to huge
savings in direct health care costs.
The results for the ST-specific measures showed that
dysfunctional modes were declining while functional modes
improved and that maladaptive schemas reduced. This
supports the assumption that the reduction of symptoms
was accomplished by the postulated mechanisms of ST.
Of particular note is that patients could profit although 40% of
them had one or two comorbid cluster–A personality disorders
and 70% had an alcohol or/and drug dependency/misuse, which
can be seen as an index of severity of the studied sample
and normally leads to exclusion from research trials in BPD
psychotherapy. Especially cluster-A personality disorders are
often considered as difficult to treat. It should be acknowledged
however that the one person with a comorbid schizotypal PD
did not profit in a general sense. This specific PD might be a
contraindication for group ST, or might need specific adaptations
of the program.
The comparison of the results of our pilot study with the
other two studies using GST shows high effects of GST on BPD
symptoms in all three studies (2.81 for the Borderline Syndrome
Index, a different outcome instrument, in the American study
vs. 2.71 for the BPDSI total score in the dutch study vs. 1.81
in our pilot study). Treatment drop-out rate was lowest in the
American study, 10% in our study and 33.3% in the Dutch study.
However, studies can only be compared to a limited extent, since
different samples, different doses of treatment and partly different
outcome measures have been investigated.
The main limitations of our study are the small sample size
and the absence of a control group. Randomized controlled
trials with larger samples are needed to further document the
efficacy of GST. Moreover, all therapists involved in the study
were very engaged and enthusiastic about ST meaning that
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FIGURE 1 | Consort patient flow chart.
there might be an allegiance effect even though this was not
the center where GST or ST were developed. It also needs to
be mentioned that all therapists received extensive training and
continuous supervision. The allegiance effect and training might
also be responsible for the relatively low drop out rate. With less
motivated, less trained and supervised clinicians drop-out might
be higher. Higher drop-out may endanger therapy effects for the
whole group, especially in a closed group setting.
In this study GST was offered in a closed format. A semi-
closed group format would offer more flexibility and would
increase implementation possibilities, as not all patients have to
start at the same time and new groupmembers can be introduced
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TABLE 3 | Observed means (M) and standard deviations (SD) for the four assessment points, results of mixed regression analyses (F- and p-value) and
estimated effect sizes (ES) for the Borderline Personality Disorder Severity Index, BPDSI (total score and subscales of all nine BPD-criteria).
Baseline M (SD) M1 M (SD) M2 M (SD) Follow-up M (SD) Time modela F d.f. p ES (Cohen’s d)b
BPDSI total score 35.74 (9.34) 29 (11.75) 24.2 (10.16) 19.34 (12.7) Assessment 15.75 1, 24.72 0.001* 1.81
Abandonment 3.17 (1.64) 3.32 (1.9) 2.18 (2.18) 1.39 (1.54) Assessment 11.84 1, 25.26 0.002* 1.25
Unstable relationships 1.78 (1.22) 2.21 (1.4) 1.83 (1.51) 1.22 (0.92) Year 3.05 1, 25.68 0.093 0.64
Identity disturbance 4.03 (2.62) 3.68 (2.77) 2.62 (2.08) 2.7 (1.8) Segmented 3.98 1, 24.56 0.057 0.53
Impulsivity 2.24 (1.16) 1.55 (0.85) 1.52 (0.8) 0.94 (0.93) Year 10.74 1, 25.20 0.003* 1.06
Parasuicidality 1.91 (1.09) 1.50 (1.47) 1.12 (0.95) 0.44 (0.5) Assessment 14.27 1, 25.03 0.001* 1.38
Affective instability 8.16 (1.62) 6.44 (2.5) 6.1 (2.6) 5.25 (3.41) Assessment 13.03 1, 24.37 0.001* 1.87
Emptiness 6.73 (2.34) 5.11 (2.69) 4.78 (3.45) 3.47 (3.32) Assessment 14.52 1, 24.37 0.001* 1.42
Angerc 2.64 (2.31) 2.02 (1.67) 1.23 (1.73) 1.56 (1.68) Segmented 4.56 1, 25.6 0.04* 0.61
Dissociation & paranoid
ideation
5.12 (2.6) 3.2 (2.21) 2.85 (2.4) 2.38 (2.31) Assessment 15.02 1, 24.75 0.001* 1.13
a Indicates whether time effect was linear over assessments (0,1,2,3) or over years (0,0.5,1,3), or segmented (0, 0.5, 1, 1).
bBased on the baseline to 3-year change from the mixed regression analysis divided by baseline SD.
cFor the mixed regression analysis, the dependent variable square was root transformed to reduce skewness.
*P < 0.05.
TABLE 4 | Observed means (M) and standard deviations (SD) for the four assessment points, results of mixed regression analyses (F- and p-value) and
estimated effect sizes (ES) for the Borderline Personality Disorder checklist (BPD, total score), the Brief Symptom Inventory (BSI), the Work and Social
Adjustment Scale (WSAS), the Global Assessment of Functioning (GAF) and the Social and Occupational Functioning Assessment Scale (SOFAS), the
Schema Mode Inventory (SMI) (mean item score for dysfunctional and functional modes) and the Young Schema Questionaire (YSQ, total score).
Baseline M (SD) M1 M (SD) M2 M (SD) Follow-upN M (SD) Time modela F d.f. p ES (Cohen’s d)b
BPD-checklist 129.11 (27,52) 116.63 (40.44) 109.71 (35.32) 100.38 (43.23) Assessment 10 1, 22.51 0.004* 1.17
BSI 2.35 (0.53) 1.83 (0.93) 2.00 (0.74) 1.50 (1.24) Assessment 11.19 1, 22.63 0.003* 1.55
WHOQOL, total score 60.07 (6.44) 66.58 (19.94) 64.09 (15.53) 73.26 (20.26) year 5.56 1, 23.41 0.027* 1.9
EuroQoL-thermometer 44.56 (24) 51.78 (26.32) 47.29 (32.06) 62.43 (32.08) year 3.24 1, 22.56 0.085 0.71
Happiness item 3.11 (0.78) 3.78 (1.09) 3.14 (1.57) 4 (1.83) Assessment 4.71 1, 25.96 0.039* 1.7
WSAS, total score 24.9 (9.85) 18.56 (14.22) 21.13 (12.02) 14.57 (13.88) Assessment 19.26 1, 23.21 <0.001* 1.09
GAF 36.5 (11.32) 48.67 (18.63) 53.25 (21.95) 51.25 (15.53) segmented 5.79 1, 25.86 0.024* 1.37
SOFAS 45.8 (12.21) 51.78 (14.87) 56.75 (21.37) 53.63 (13.76) Segmented 5.18 1, 24.70 0.032* 0.84
SMI, dysfunctional modes 3.62 (0.55) 3.04 (0.76) 3.02 (0.74) 2.91 (1.03) Assessment 14.9 1, 21.64 0.001* 1.33
SMI, functional modes 2.74 (0.46) 3.33 (0.84) 3.06 (0.69) 3.57 (0.96) Assessment 8.34 1, 21.93 0.009* 1.51
YSQ total 62.2 (9.39) 52.58 (16.28) 53.97 (14.6) 50.37 (17.19) Assessment 11.75 1, 22.40 0.002* 1.34
a Indicates whether time effect was linear over assessments (0,1,2,3) or over years (0,0.5,1,3), or segmented (0, 0.5, 1, 1).
bBased on the baseline to 3-year change from the mixed regression analysis divided by baseline SD.
*P < 0.
TABLE 5 | Days of hospitalizations per year in the year before baseline, in year 1–3.
Days of hospitalization/year Year before baseline Year 1 Year 2 Year 3 F d.f. p ES1 (Cohen’s d)
Original scale (M) 92.9 15.2 22.5 3.8
Transformed scale (M) (Poisson regression) (s.e.) 4.53 (0.20) 2.72 (0.49) 3.11 (0.40) 1.34 (0.97) 19.14 1, 38 <0.001* 5.13
1Effect Size Cohen’s d based on change over 3 years and baseline SD based on transformed variables from Poisson regression.
*P < 0.05.
if patients drop out. However, a semi-closed group format
might reduce safety and attachment among group members and
therefore interfere with the positive effects of GST. A semi-closed
group format has already been developed and tested in a pilot
study for inpatients (Reiss et al., 2013). As a semi-closed group
format might be helpful for implementation and dissemination
in routine health care, the protocol needs to be tested in larger
clinical trials also for outpatients.
As far as we know our study is the first study examining
outpatient ST for BPD in Germany, and the third study on GST
in outpatient care. The results of this pilot study are promising
and give us important information of the benefits of structured
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outpatient treatment programs with GST encouraging further
implementation and dissemination.
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